Search hospitals > Kentucky > Louisville
University of Louisville
Claim this profileLouisville, Kentucky 40202
Global Leader in Fibrosis
Global Leader in Crohn's Disease
Conducts research for Stroke
Conducts research for Cancer
Conducts research for Inflammatory Bowel Disease
476 reported clinical trials
41 medical researchers
Summary
University of Louisville is a medical facility located in Louisville, Kentucky. This center is recognized for care of Fibrosis, Crohn's Disease, Stroke, Cancer, Inflammatory Bowel Disease and other specialties. University of Louisville is involved with conducting 476 clinical trials across 549 conditions. There are 41 research doctors associated with this hospital, such as Rebecca Redman, MD, Neal E. Dunlap, Gerald W Dryden, MD, Ph.D, and Robert C. Martin, MD,PhD,FACS.Top PIs
Rebecca Redman, MDJames Graham Brown Cancer Center3 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
15 reported clinical trials
28 drugs studied
Neal E. DunlapThe James Graham Brown Cancer Center at University of Louisville3 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
15 reported clinical trials
36 drugs studied
Gerald W Dryden, MD, Ph.DUniversity Of Louisville3 years of reported clinical research
Studies Inflammatory Bowel Disease
Studies Ulcer
10 reported clinical trials
11 drugs studied
Robert C. Martin, MD,PhD,FACSUniversity of Louisville6 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
9 reported clinical trials
16 drugs studied
Clinical Trials running at University of Louisville
Crohn's Disease
Gastroparesis
Spinal Cord Injury
Heart Failure
Stroke
Liver Cancer
Inflammatory Bowel Disease
Ulcerative Colitis
Adenocarcinoma
Cancer
Vedolizumab + Adalimumab/Ustekinumab
for Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab together with ustekinumab in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual targeted treatment. The study is conducted in two parts. In Part A, participants will receive the dual targeted treatment (vedolizumab together with either adalimumab or ustekinumab). In part B, participants will receive vedolizumab only. Part B will include participants who responded to the treatment in Part A. Each participant will be followed up for at least 26 weeks after the last dose of treatment.
Recruiting3 awards Phase 410 criteria
Risankizumab
for Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms including abdominal pain, diarrhea, tiredness, and weight loss. This study will assess how safe and effective risankizumab subcutaneous (SC) induction treatment is in treating moderately to severely active CD in adult participants. Risankizumab is an approved drug for adults with CD. This study comprises of a Period A and a Period B. In Period A, participants are placed in 1 of 2 groups to receive either risankizumab SC or Placebo. In Period B, based on response, participants will receive risankizumab SC Dose B or Placebo. Participants who do not have improvement in CD symptoms at Week 12 will receive risankizumab SC Dose C and participants with worsening CD symptoms in period B will receive risankizumab SC. Approximately 276 adult participants with a diagnosis of moderately to severely active CD will be enrolled in approximately 250 sites globally. Participants will receive SC induction treatment of risankizumab or matching placebo for up to 24 weeks in Period A and B. The duration of the study will be approximately 49 weeks.
Recruiting1 award Phase 34 criteria
Guselkumab
for Crohn's Disease
This trial tests a medicine called guselkumab on adults with severe Crohn's disease who haven't responded to other treatments. The study will last over two years and will check both how well the medicine works and its safety. Guselkumab is already approved for treating other conditions like plaque psoriasis and psoriatic arthritis.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Louisville?
University of Louisville is a medical facility located in Louisville, Kentucky. This center is recognized for care of Fibrosis, Crohn's Disease, Stroke, Cancer, Inflammatory Bowel Disease and other specialties. University of Louisville is involved with conducting 476 clinical trials across 549 conditions. There are 41 research doctors associated with this hospital, such as Rebecca Redman, MD, Neal E. Dunlap, Gerald W Dryden, MD, Ph.D, and Robert C. Martin, MD,PhD,FACS.
Where is University of Louisville located?
To reach the University of Louisville Hospital, take I-65 to the Brooks Street exit and follow signs to the parking garage at 530 S Jackson St. Alternatively, the UofL Outpatient Parking at Chestnut and Preston streets offers a covered pedestrian walkway connecting to the hospital.
Who should I call to ask about financial aid or insurance network?
**University of Louisville Hospital Financial Assistance:**
- **Central Business Office:** For assistance with payment plans and determining eligibility for public programs like Medicaid, call 502-588-4770 or speak with a financial counselor.
- **Billing and Claims:** For questions, contact the Campus Health Billing Clerk at 502-852-6519 or email stuins@louisville.edu or tamra.lambert@louisville.edu.
- **General Inquiries:** For appointments and information, call Cardinal Station at 502-852-6479 or the Health Sciences Center Office at 502-852-6446.
What insurance does University of Louisville accept?
The University of Louisville accepts a wide range of insurance plans, including most commercial insurance companies, Medicare, Medicaid MCOs, and Tricare. Campus Health Services files claims with these insurers but does not accept cash payments. The University of Louisville Health Plan (ULH) offers high coverage with UofL providers in the Anthem network and provides a PPO Plan with in-network and out-of-network coverage, requiring members to pay costs up to the deductible before it covers services.
What awards or recognition has University of Louisville received?
The University of Louisville Hospital, located in Louisville, Kentucky, is renowned for its outstanding nursing care, earning the DAISY Award for clinical skills and extraordinary compassion. It is integral to the University of Louisville Health Sciences Center, supporting research in health hazard preparedness, surgical techniques, environmental health sciences, cardiovascular innovation, and electrooptics. The hospital actively participates in clinical trials in collaboration with the University of Louisville School of Medicine, advancing research and development of new treatments and cures.